Guidelines for good database selection and use in pharmacoepidemiology research

The use of healthcare databases in research provides advantages such as increased speed, lower costs and limitation of some biases. However, database research has its own challenges as studies must be performed within the limitations of resources, which often are the product of complex healthcare systems. The primary purpose of this document is to assist in the selection and use of data resources in pharmacoepidemiology, highlighting potential limitations and recommending tested procedures. This guidance is presented as a detailed text with a checklist for quick reference and covers six areas: selection of a database, use of multiple data resources, extraction and analysis of the study population, privacy and security, quality and validation procedures and documentation. Copyright © 2011 John Wiley & Sons, Ltd.

[1]  Sebastian Schneeweiss,et al.  Multivariate‐adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases , 2010, Pharmacoepidemiology and drug safety.

[2]  R. Platt,et al.  Distributed Health Data Networks: A Practical and Preferred Approach to Multi-Institutional Evaluations of Comparative Effectiveness, Safety, and Quality of Care , 2010, Medical care.

[3]  N. Dreyer,et al.  Registries for Evaluating Patient Outcomes: A User’s Guide , 2010 .

[4]  David Atkins,et al.  Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  M. Epstein,et al.  Guidelines for good pharmacoepidemiology practices (GPP) , 2008 .

[6]  R. Hughes,et al.  Guillain-Barré syndrome , 1994, The Lancet.

[7]  L. Smeeth,et al.  Validation and validity of diagnoses in the General Practice Research Database: a systematic review , 2010, British journal of clinical pharmacology.

[8]  Douglas G Altman,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. , 2014, International journal of surgery.

[9]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[10]  Peter Davey,et al.  A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[11]  G. Hall Validation of death and suicide recording on the THIN UK primary care database , 2009, Pharmacoepidemiology and drug safety.

[12]  W. Bilker,et al.  Descriptive analyses of the integrity of a US Medicaid claims database , 2003, Pharmacoepidemiology and drug safety.